William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Downgrades Dave & Buster's (PLAY) to Market Perform
-
NewAmsterdam Pharma (NAMS) Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
-
NewAmsterdam Pharma Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
-
SOLVD Health to Present at William Blair’s Innovator Series: Life Science Tools and Diagnostics
-
Sponsors Announced for the 2025 ICR Conference
-
Cardiff Oncology (CRDF) Prices Oversubscribed $40 Million Underwritten Registered Direct Offering
-
Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering
-
Arthur J. Gallagher (AJG) Announces Pricing of $8.5 Billion of Shares of Its Common Stock
-
Arthur J. Gallagher & Co. Announces Pricing of $8.5 Billion of Shares of Its Common Stock
-
William Blair on Underperform Rated Palantir (PLTR), 'the company’s revenue is still tracking to miss management’s 2025 target '
-
Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total G
-
Orion Announces Wealthtech Industry Leader Chris Shutler as Head of Strategy
-
Janux Therapeutics (JANX) Prices 5.32M Share Offering at $63/sh
-
Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
-
Eagle Point Credit Company Inc. Prices $100 Million Public Offering of Notes
-
Wynnchurch Capital Exits Infra Pipe Solutions
-
William Blair Reiterates Underperform Rating on Palantir Technologies Inc. (PLTR)
-
William Blair Starts Vigil Neuroscience Inc (VIGL) at Outperform
-
Eagle Point Credit Company Inc. Announces Offering of Notes
-
Janux Therapeutics (JANX) Announces Proposed $300M Share Offering
-
Janux Therapeutics Announces Proposed Public Offering
-
CCMP Growth Advisors Acquires Combined Caterers
-
William Blair on Janux Therapeutics (JANX): 'Exceeding Investor Expectations and Raising the Bar in mCRPC'
-
ServiceTitan Announces Launch of Initial Public Offering
-
RAMACO RESOURCES, INC. COMPLETES $50,000,000 SENIOR UNSECURED NOTES OFFERING
-
Coursera to Hold a Virtual Q&A Session With Chairman and Co-Founder, Andrew Ng
-
William Blair Starts Nasdaq OMX Group Inc. (NDAQ) at Outperform
-
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
-
Form 40-17G WILLIAM BLAIR FUNDS
-
RAMACO RESOURCES, INC. ANNOUNCES PRICING OF SENIOR UNSECURED NOTES OFFERING
-
William Blair Reiterates Outperform Rating on NVIDIA (NVDA)
